Summary of findings table ‐ Oral small molecule inhibitors (apremilast or baricitinib) vs placebo
Incidence of serious adverse events · adults with alopecia areata
Summary of findings table ‐ Oral small molecule inhibitors… showed no clear difference in incidence of serious adverse events compared with placebo (low certainty).
1 finding from 1 review
- RR 1.47 [0.6, 3.6]3 studies · 1224 participantsLow